SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-20-005032
Filing Date
2020-02-18
Accepted
2020-02-18 16:16:43
Documents
59
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K abio-10k_20191231.htm 10-K 2188273
2 EX-4.7 abio-ex47_80.htm EX-4.7 36572
3 EX-23.1 abio-ex231_7.htm EX-23.1 3754
4 EX-31.1 abio-ex311_6.htm EX-31.1 14991
5 EX-31.2 abio-ex312_9.htm EX-31.2 16101
6 EX-32.1 abio-ex321_8.htm EX-32.1 9345
  Complete submission text file 0001564590-20-005032.txt   5665123

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT abio-20191231.xml EX-101.INS 839943
8 XBRL TAXONOMY EXTENSION SCHEMA abio-20191231.xsd EX-101.SCH 37703
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abio-20191231_cal.xml EX-101.CAL 36669
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abio-20191231_def.xml EX-101.DEF 117725
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE abio-20191231_lab.xml EX-101.LAB 390525
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20191231_pre.xml EX-101.PRE 268519
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22873 | Film No.: 20625499
SIC: 2835 In Vitro & In Vivo Diagnostic Substances